Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib

Bibliographic Details
Title: Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib
Authors: Cortes, J. E., Nicolini, F. E., Wetzler, M., Lipton, J. H., Akard, L., Craig, A., Nanda, N., Benichou, A. C., Leonoudakis, J., Khoury, H. J.
Source: CLINICAL LYMPHOMA MYELOMA AND LEUKEMIA. 13(5):584-591
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN338828870&indx=1&recIds=ETOCRN338828870
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:21522650
Published in:CLINICAL LYMPHOMA MYELOMA AND LEUKEMIA
Language:English